Keywords: ec, approves, ucb, xyrem, european, commission, approved

EC approves UCB's Xyrem

Article | 19 March 2007

Print This

The European Commission has approved Belgian drugmaker UCB's Xyrem (sodium oxybate) for the treatment of narcolepsy with cataplexy in adult ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in